Introduction
Mortality from coronary heart disease has been decreasing in New Zealand at roughly 2% a year since 1968,' and this could be due to a decreasing incidence of the disease or of fatal cases, or both. In Auckland during 1974-81 the rate of acute myocardial infarction did not decrease2 and one and three year survival after infarction did not show a clear improvement,4 although the rate of sudden death from coronary causes declined steadily. ' We compared the three year survival rates after myocardial infarction in 1966-7 and 1981-2, taking into account changes in the severity of the illness over this time.
Patients and methods 1966-7-We used a subset of data from all 757 patients with acute myocardial infarction admitted to the three hospitals in Auckland between March 1966 and February 1967.S The severity of infarction was measured as the coronary prognostic index, which is derived from the patient's age; size of the heart and state of the lung, assessed from an x ray film of the chest at the time of infarction; and history of myocardial infarction." The coronary prognostic index was calculated for each of the patients at admission. We obtained information on 
showing the effect of the index. For example, compared with a patient aged under 50 with no enlargement of the heart, no abnormalities of the lung, and no history of myocardial infarction (coronary prognosis index=0 98) a patient aged 60-69 with an enlarged heart, pulmonary oedema, and a history of myocardial infarction (coronary prognostic index=13 2) would have (95% confidence interval 6 1 to 28 6) times the chance of dying before three years. The rate of improvement in survival between the groups in our study did not seem to differ appreciably with any of the categories of severity of infarction.
Discussion
The three year survival rates after a definite myocardial infarction in 1966-7 and 1981-2, controlling for severity of the infarction, showed an improvement for 1981-2, although the severity of infarction in the survivors at four weeks had increased. This change in severity is contrary to that which we had predicted,4 and we do not know how much of it was due to the change in the criteria defining definite infarction, in the natural course of the disease, or in the effects of changes in management.
The use of data from only one of the three hospitals in Auckland should not have caused bias as admission to hospital is based on geographical criteria and not on severity of disease. The definitions of definite myocardial infarction were different between the groups, the diagnostic criteria for the 1980-1 group being slightly more rigorous than those for the 1966-7 group and therefore selecting more severely ill patients. The degree of difference cannot be estimated but it is unlikely to have accounted for the observed changes in severity. A criterion for entry to the study was survival at four weeks after the onset of myocardial infarction, which could have led to a difference in severity of infarction between the groups because of changes in management and hence to a difference in the composition of the patients entering the study at the different times. Again, the effect of this change cannot be measured, although it is unlikely to have had any appreciable effect on the three year survival.
We do not know whether survival improved gradually or over a short period during the follow up as information on coronary prognostic index and three year survival was not available between the two periods of study. We have examined trends in survival over a shorter time interval and failed to show a significant improvement.4 A Swedish study, in which the criteria for inclusion were age less than 60, first myocardial infarction, and survival to discharge from hospital, showed an improvement in survival which may have occurred from 1968-9 to 1970-1.9 Our data are also consistent with this interpretation. Improved survival after myocardial infarction during 1970-80 has also been reported in Minnesota but has been mostly attributed to improved survival in hospital.'0 Severity of infarction seemed to have increased with time and hence could not explain the improved survival. As the Minnesota study began in 1970 it may possibly have missed the period when survival improved in patients alive at discharge from hospital.
The use of i blockers increased considerably from 1966-7 to 1981-2, and coronary artery operations are now widely used for treating severe angina. Neither of these factors is, however, sufficient to explain the change in survival, particularly if the improvement occurred in the early part of the period of study. About 30% of patients discharged from hospitals in Auckland BMJ VOLUME 297 20-27 AUGUST 1988
l 1966----in 1981 were estimated to be taking ji blockers,' but nearly all of them would have to have survived because of fl blockade for this to account solely for the increased survival rates; this is unlikely given the modest effect on survival of j i blockers taken after infarction. 12 The hazards of continued smoking after myocardial infarction became widely recognised in the early 1970s,' and as the need to stop smoking now receives much more emphasis in hospital than it did in the 1960s we suspect that this may be the most important factor contributing to improved survival. Our results suggest that an improvement in long term survival after myocardial infarction contributed to the decline in mortality from coronary heart disease in New Zealand, but there is as yet no evidence that it is continuing to do so. Further reductions in mortality from coronary heart disease are likely only if emphasis is placed on primary prevention. 
Abstract
Study objective-To determine whether postmenopausal oestrogen use affects the risk of dying from stroke.
Design-Postal questionnaire survey to elicit details of oestrogen replacement therapy and potential risk modifiers.
Setting-Californian retirement community. Participants-All 22 781 residents of community (white, affluent, weli educated) contacted by mail and phone; 13 986 (61%, median age 73) responded, including 8882 women. These formed cohort for mortality foliow up, using health department death certification. Only 13 lost to follow up, apparently not deceased, but 34 excluded because no information on oestrogen use.
Interventions-None. End point-Mortality rate from stroke compared in women who did and did not receive oestrogen replacement treatment.
Measurements and main results-Age adjusted mortality rates were computed using internal standard and four age groups. By January 1987 there had been 1019 deaths in the cohort. Twenty out of 4962 women who used oestrogen replacement treatment died from stroke compared with 43 out of 3845 women who did not use oestrogen replacement treatment: relative risk 0 53, 95% confidence interval 0*31 to 0*91. Protection was found in all age groups except the youngest and was unaffected by adjustment for possible confounding factors (hypertension, smoking, alcohol, body mass index, exercise).
Conclusions-Oestrogen replacement treatment protects against death due to stroke.
Introduction
Although mortality rates are declining, stroke continues to be the third leading cause of death in the United States after heart disease and cancer' as well as a major contributor to disability. Since stroke is often fatal and the impact of treatment on prognosis is limited, control of the disease must be through primary prevention.
Recent cohort and case-control studies have suggested that the use of oestrogen replacement treatment by postmenopausal women protects against death and admission to hospital due to cardiovascular disease.2'-" As some of the major risk factors for heart disease are also risk factors for stroke, we examined the association of postmenopausal hormone use and stroke in a prospective study conducted in a retirement community in southern California. The study design provided the opportunity of obtaining details on potential risk modifiers, such as prior heart disease, hypertension, cigarette smoking, alcohol intake, exercise, and weight, as well as on the dose and duration ofuse ofoestrogens.
Methods
In June 1981 a health questionnaire was mailed to all residents of Leisure World, Laguna Hills, a retirement community near Los Angeles, California. New residents who moved into the community after this date were mailed the questionnaire in June 1982, June 1983, and October 1985. Residents of this community are almost entirely white, moderately affluent, and well educated. The residents' median age was 73 at the time of the initial mailing, and about two thirds were women. After three mailings and follow up telephone contact 13 986 (61%) of the 22 781 residents returned questionnaires; 8882 ofthese respondents were women.
The health questionnaire requested information on certain medical diagnoses including stroke, angina, myocardial infarction, and hypertension; height and weight; consumption ofcigarettes and alcohol; and, for women, menstrual and reproductive events, including gynaecological operations. Detailed information was collected on the use of oestrogens during the meno-
